Article thumbnail

Advances in Glucocorticoid-Induced Osteoporosis

By Debby den Uyl, Irene E. M. Bultink and Willem F. Lems

Abstract

Glucocorticoid-induced osteoporosis (GIOP) is one of the most important side effects of glucocorticoid use, as it leads to an increased risk of fractures. Recently, many published studies have focused on the cellular and molecular mechanisms of bone metabolism, the pathophysiology of GIOP, and the intervention options to prevent GIOP. In this review, recent advances in GIOP are summarized, particularly recent progress in our understanding of the mechanisms of GIOP resulting in improved insight that might result in the development of new treatment options in the near future

Topics: Article
Publisher: Current Science Inc.
OAI identifier: oai:pubmedcentral.nih.gov:3092927
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles